Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical and Experimental Hematopathology : JCEH|July 2, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant settingShuji Momose, Jun-Ichi Tamaru
Rheumatology International|October 23, 2009
Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomasHaruo Abe, Shuji Momose, Tsutomu Takeuchi
Biochemical and Biophysical Research Communications|March 24, 2007
N-terminal hamartin-binding and C-terminal GAP domain of tuberin can separate in vivoShuji Momose, Toshiyuki Kobayashi, Norihiro Tada, et al.
International Journal of Oncology|July 18, 2017
Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancerTakahisa Yamashita, Morihiro Higashi, Shuji Momose, et al.
Case Reports in Urology|June 2, 2018
Retroperitoneal Cystic Nodal Metastasis of Renal Cell CarcinomaTakahisa Yamashita, Makoto Morozumi, Morihiro Higashi, et al.
Case Reports in Pediatrics|December 15, 2022
A Case of Kikuchi's Disease Without Cervical LymphadenopathyShinya Tomori, Seigo Korematsu, Taichi Momose, et al.
Cancer Science|April 24, 2003
Renal carcinogenesis: genotype, phenotype and dramatypeOkio Hino, Toshiyuki Kobayashi, Shuji Momose, et al.
Internal Medicine (Tokyo, Japan)|December 10, 2025
The Use of Vessel Wall Imaging for Making an Early Diagnosis of Giant Cell Arteritis in a Case with Cerebral InfarctionMasaomi Yamamoto, Tomohisa Dembo, Tetsuo Yamaga, et al.
The American Journal of Pathology|December 31, 2022
Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder CancerTakahisa Yamashita, Morihiro Higashi, Hironori Sugiyama, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 31, 2024
Evaluation of the effects of MCVAC conditioning regimen followed by autologous hematopoietic stem cell transplantation in patients with relapsed and refractory Hodgkin lymphoma: A single-institution retrospective studyKen Naganuma, Yasuyuki Takahashi, Tomoe Anan, et al.
Pageof 7